New York (September 7, 2017) – The New York Academy of Medicine has selected three recipients for its prestigious 2017-2018 Glorney-Raisbeck Fellowship Award in Cardiovascular Diseases: Amanda Doran, MD, PhD, MS, of Columbia University Medical Center, Michael Garshick, MD, of New York University Langone Medical Center, and Daniele Massera, MD, MS, of Montefiore Medical Center, Albert Einstein College of Medicine. Dr. Doran's research project is titled "CaMKIIγ in Advanced Atherosclerosis and Insulin Resistance." Dr. Garshick’s research project is titled “The Impact of Microbiome Alternations on Atherosclerotic Plaque Regression.” Dr. Massera’s research project is titled “Markers of Bone Turnover and Risk of Incident Fractures, Aortic Stenosis and Diabetes Mellitus in Older Women.”
“The Academy is deeply committed to conducting and supporting research that provides evidence to improve the public’s health,” said Academy President Judith A. Salerno, MD, MS. “Through the 2017 Glorney-Raisbeck Fellowship Awards, we are pleased to support the research of Dr. Garshick and Dr. Massera to better understand inflammation and abnormal bone metabolism as they relate to cardiovascular diseases.”
Each year, The New York Academy of Medicine awards more than $400,000 in grants and fellowships to medical students, seasoned physicians, and investigators to support the advancement of health care studies.
The Glorney-Raisbeck Fellowship Award in Cardiovascular Diseases is a one-year, $70,000 grant awarded in support of research projects seeking better understanding of the causes, prevention, and treatment of cardiovascular disease and that will advance the academic careers of young physician investigators. A committee composed of experts in cardiovascular research conducts an in-depth review of the applications to select the fellowship award recipients.
Dr. Doran is currently completing her fellowship in Cardiovascular Diseases at Columbia. For the past two years, she has been under the mentorship of Dr. Ira Tabas, studying the molecular biology of atherosclerosis with a particular interest in the mechanisms linking insulin resistance to atherogenesis. With the support of the 2017-2018 Glorney-Raisbeck Fellowship, Dr. Doran aims to explore the role of the enzyme Calcium/calmodulin-dependent protein kinase II (CaMKII) in the regulation of insulin resistance and atherosclerosis.
Dr. Doran received her BA from Wellesley College in 2001 where she majored in Biological Chemistry. After college, she spent two years working at Tufts University cultivating an interest in basic science research. From there, she went on to the University of Virginia where she received her MD and PhD degrees, working in the lab of Dr. Coleen McNamara. Dr. Doran moved to New York City in 2011 to begin her training in Internal Medicine at Columbia University Medical Center.
Dr. Garshick is currently a post-doctoral research fellow in Cardiovascular Medicine and completing a Master’s Degree in Clinical Investigation at New York University Langone Medical Center. His research focus is on the role of inflammation and cardiovascular disease. He is currently investigating the contribution of the gut microbiome to inflammation and atherosclerosis. The microbiome has been linked to many inflammatory pathways and his study is designed to understand how microbiome alterations may impact plaque regression in a mouse model. For this project, Dr. Garshick is receiving co-mentorship from Dr. Edward Fisher, the Leon H. Charney Professor of Cardiovascular Medicine and Director of the Center for Prevention of Cardiovascular Disease, as well as Dr. Martin Blaser, the Muriel and George Singer Professor of Medicine and Director of the Human Microbiome Program, all at New York University Medical Center. Dr. Garshick has presented and published his preliminary work at the Atherosclerosis, Thrombosis and Vascular Biology Scientific Sessions meeting and received a Distinction in Clinical Investigation Award through New York University Medical Center for his work on atherosclerosis and the microbiome.
Dr. Garshick is originally from Newton, Massachusetts, and completed his undergraduate studies at Tufts University, graduating cum laude. He received his medical degree from Tufts University where he was selected to the Alpha Omega Alpha Honor Medical Society. Dr. Garshick completed his Internal Medicine training at New York – Presbyterian/Columbia University Medical Center and his Cardiology Fellowship at New York University Langone Medical Center. While in fellowship, Dr. Garshick was Chief Fellow in the Cardiology Clinic at Bellevue Hospital and was elected as co–Vice President of the American Heart Association Fellows Society of New York.
Dr. Massera is a Fellow in Cardiovascular Disease at Montefiore Medical Center, Albert Einstein College of Medicine. His research interest lies in the relationship of bone mineral metabolism and valve calcification. The Glorney-Raisbeck Fellowship Award will support Dr. Massera’s project entitled “Markers of Bone Turnover and Risk of Incident Fractures, Aortic Stenosis and Diabetes Mellitus in Older Women,” which will evaluate the impact of abnormal bone metabolism in three common conditions affecting our aging population. Dr. Jorge Kizer, MD, MSc, Associate Professor of Medicine, Epidemiology and Population Health, and Director of Clinical Cardiovascular Research in the Department of Medicine, serves as his mentor.
Dr. Massera received his medical degree from the Medical University of Vienna, in Austria, and completed his residency in Internal Medicine at Montefiore Medical Center, Albert Einstein College of Medicine, where he has remained for his Fellowship in Cardiovascular Disease. During his fellowship, he completed the Clinical Research Training Program at Albert Einstein College of Medicine and received a Master of Science degree in Clinical Research Methods. For his thesis work, he investigated the association between bone mineral density and aortic and mitral valve calcification in participants of the Cardiovascular Health Study.
Dr. Massera has received teaching and research awards at Montefiore Medical Center and at the Albert Einstein College of Medicine. He has previously served as Vice President of Education for the American Heart Association Fellows Society of Greater New York and as Fellow-In-Training member of the American College of Cardiology National Cardiovascular Data Registry PINNACLE Research and Publication Subcommittee.
Applications for the Academy’s 2018-19 research fellowships and summer 2018 student grants will open in early October 2017. Please visit the Academy’s website for details and application materials.
The Academy acknowledges the Corlette Glorney Foundation for its generous support of the Glorney-Raisbeck Fellowship Award in Cardiovascular Diseases.
About The New York Academy of Medicine
The New York Academy of Medicine advances solutions that promote the health and well-being of people in cities worldwide.
Established in 1847, The New York Academy of Medicine continues to address the health challenges facing New York City and the world’s rapidly growing urban populations. We accomplish this through our Institute for Urban Health, home of interdisciplinary research, evaluation, policy, and program initiatives; our world class historical medical library and its public programming in history, the humanities and the arts; and our Fellows program, a network of more than 2,000 experts elected by their peers from across the professions affecting health. Our current priorities are healthy aging, disease prevention, and eliminating health disparities. For more information, visit www.nyam.org.
View our COVID-19 Safety Protocols for attending NYAM public events.